![David Epstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Epstein
Fondatore presso
Pairx Bio Pte Ltd.
Patrimonio netto: - $ in data 31/07/2026
Profilo
David M.
Epstein was the founder of Archemix Corp., founded in 2001, where the title held was Vice President-Biology from 2001 to 2003.
Dr. Epstein was the founder of Black Diamond Therapeutics, Inc., founded in 2014, holding the title of Director from 2023 to 2024.
Dr. Epstein is the founder of Pairx Bio Pte Ltd., founded in 2022, currently serving as President, Chief Executive Officer & Director since 2023.
The current job is Independent Director at Gyre Therapeutics, Inc. starting in 2024.
Former jobs include Director at MetaStat, Inc. from 2013 to 2015, Chief Scientific Officer-Oncology & Senior VP at OSI Pharmaceuticals, Inc. from 2006 to 2013, and Associate Professor at Duke-NUS Graduate Medical School Singapore.
Education includes a doctorate from Brandeis University and an undergraduate degree from Lewis & Clark College (Oregon).
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
-.--% | 10/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Posizioni attive di David Epstein
| Società | Posizione | Inizio |
|---|---|---|
Pairx Bio Pte Ltd.
 Pairx Bio Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company which develops and generates cancer immunotherapies targeting shared tumor-associated antigens derived from aberrantly spliced proteins | Fondatore | 01/06/2022 |
Precedenti posizioni note di David Epstein
| Società | Posizione | Fine |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Fondatore | 01/06/2024 |
| METASTAT, INC. | Direttore/Membro del Consiglio | 01/04/2015 |
| OSI PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 31/03/2013 |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Provides molecular biology research to develop new drugs | Fondatore | 01/01/2003 |
Duke-NUS Graduate Medical School Singapore
 Duke-NUS Graduate Medical School Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formazione di David Epstein
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
58
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Provides molecular biology research to develop new drugs | Commercial Services |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lewis & Clark College (Oregon)
 Lewis & Clark College (Oregon) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke-NUS Graduate Medical School Singapore
Duke-NUS Graduate Medical School Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MetaStat, Inc.
 MetaStat, Inc. Electrical ProductsProducer Manufacturing Develops cancer diagnostics technologies | Producer Manufacturing |
Black Diamond Therapeutics, Inc.
 Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Pairx Bio Pte Ltd.
Pairx Bio Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company which develops and generates cancer immunotherapies targeting shared tumor-associated antigens derived from aberrantly spliced proteins | Commercial Services |
